| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpędek-Kamińska, Ireneusz Majstere. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences. vol 25. issue 1. 2024-01-11. PMID:38203531. |
parkinson's disease (pd) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αsyn) protein aggregates. |
2024-01-11 |
2024-01-13 |
Not clear |
| E R G Plini, M C Melnychuk, A Harkin, M J Dahl, M McAuslan, S Kühn, R T Boyle, R Whelan, R Andrews, S Düzel, J Drewelies, G G Wagner, U Lindenberger, K Norman, I H Robertson, P M Dockre. Dietary Tyrosine Intake (FFQ) Is Associated with Locus Coeruleus, Attention and Grey Matter Maintenance: An MRI Structural Study on 398 Healthy Individuals of the Berlin Aging Study-II. The journal of nutrition, health & aging. vol 27. issue 12. 2023-12-28. PMID:38151868. |
degradation of the neuromodulatory pathways, (comprising the cholinergic, dopaminergic, serotoninergic and noradrenergic systems) is observed in neurodegenerative diseases and impairs the proper biosynthesis of key neuromodulators from micro-nutrients and amino acids. |
2023-12-28 |
2023-12-30 |
Not clear |
| Surabhi Shastry, Junkai Hu, Mingyao Ying, Xiaobo Ma. Cell Therapy for Parkinson's Disease. Pharmaceutics. vol 15. issue 12. 2023-12-23. PMID:38139997. |
parkinson's disease (pd) is a neurodegenerative disease characterized by the progressive loss of dopaminergic neurons of the substantia nigra pars compacta with a reduction in dopamine concentration in the striatum. |
2023-12-23 |
2023-12-25 |
Not clear |
| Myung Ji Kim, Su Hee Cho, Yongbo Seo, Sang-Dae Kim, Hae-Chul Park, Bum-Joon Ki. Neuro-Restorative Effect of Nimodipine and Calcitriol in 1-Methyl 4-Phenyl 1,2,3,6 Tetrahydropyridine-Induced Zebrafish Parkinson's Disease Model. Journal of Korean Neurosurgical Society. 2023-12-22. PMID:38130142. |
parkinson's disease (pd) is one of the most prevalent neurodegenerative diseases, characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta. |
2023-12-22 |
2023-12-24 |
human |
| Meng-Fan Yao, Tao Dang, Hua-Jun Wang, Xiao-Zhong Zhu, Chen Qia. Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease. Behavioural brain research. 2023-12-16. PMID:38103871. |
parkinson's disease (pd) is a neurodegenerative disease characterized by progressive loss of dopaminergic (da) neurons in the substantia nigra pars compacta (snc) and the presence of lewy bodies (lbs) or lewy neurites (lns) which consist of α-synuclein (α-syn) and a complex mix of other biomolecules. |
2023-12-16 |
2023-12-21 |
human |
| Andrea Di Credico, Amélie Weiss, Massimo Corsini, Giulia Gaggi, Barbara Ghinassi, Johannes H Wilbertz, Angela Di Baldassarr. Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls. Scientific reports. vol 13. issue 1. 2023-12-11. PMID:38081991. |
parkinson's disease (pd) is the second most common neurodegenerative disease and is characterized by the loss of midbrain dopaminergic neurons. |
2023-12-11 |
2023-12-17 |
human |
| Heba M Mansour, Ahmed F Mohamed, Mahmoud M Khattab, Aiman S El-Khati. Heat Shock Protein 90 in Parkinson's disease: Profile of a serial killer. Neuroscience. 2023-12-01. PMID:38040085. |
parkinson's disease (pd) is the second most common neurodegenerative disease, characterized by abnormal α-synuclein misfolding and aggregation, mitochondrial dysfunction, oxidative stress, as well as progressive death of dopaminergic neurons in the substantia nigra. |
2023-12-01 |
2023-12-10 |
Not clear |
| Lanxin Li, Yang Zhang, Zhengqian Chen, Ruyong Yao, Zhongqiu Xu, Can Xu, Fujie He, Haitao Pei, Cui Ha. SIRT1-dependent mitochondrial biogenesis supports therapeutic effects of vidarabine against rotenone-induced neural cell injury. Heliyon. vol 9. issue 11. 2023-12-01. PMID:38027872. |
parkinson's disease (pd) is the second most common neurodegenerative disease in the world, which is distinguished by the loss of dopaminergic (da) neurons in the substantia nigra and the formation of intraneuronal. |
2023-12-01 |
2023-12-10 |
mouse |
| Haydar M Al-Kuraishy, Ali I Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Mostafa M Bahaa, Aya Talal Zaidalkiani, Ammar Al-Faraga, Gaber El-Saber Batih. Calprotectin in Parkinsonian Disease: Anticipation and Dedication. Ageing research reviews. 2023-11-26. PMID:38008403. |
parkinson's disease (pd) is a neurodegenerative disease due to degeneration of dopaminergic neurons (dns) in the substantia nigra pars compacta (snpc). |
2023-11-26 |
2023-11-28 |
Not clear |
| Min Hyung Seo, Dasom Kwon, Soo-Hwan Kim, Sujung Ye. Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson's Disease. International journal of molecular sciences. vol 24. issue 22. 2023-11-25. PMID:38003598. |
parkinson's disease (pd) is a globally common progressive neurodegenerative disease resulting from the loss of dopaminergic neurons in the brain. |
2023-11-25 |
2023-11-28 |
mouse |
| Katherine S Morton, Jessica H Hartman, Nathan Heffernan, Ian T Ryde, Isabel W Kenny-Ganzert, Lingfeng Meng, David R Sherwood, Joel N Meye. Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration. BMC biology. vol 21. issue 1. 2023-11-11. PMID:37950228. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease and is characterized by the progressive death of dopaminergic neurons in the brain. |
2023-11-11 |
2023-11-20 |
caenorhabditis_elegans |
| Jeffrey Kim, Etienne W Daadi, Elyas Sebastien Daadi, Thomas Oh, Michela Deleidi, Marcel M Daad. Cells. vol 12. issue 21. 2023-11-10. PMID:37947628. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the loss of midbrain dopaminergic neurons which leads to impaired motor and cognitive functions. |
2023-11-10 |
2023-11-20 |
Not clear |
| Pragati, Surajit Sarka. Targeted upregulation of dMyc restricts JNK-mediated degeneration of dopaminergic neurons in the paraquat-induced Parkinson's disease model of Drosophila. Neuroscience research. 2023-11-01. PMID:37913999. |
parkinson's disease is the second most common neurodegenerative disease characterized by the loss of dopaminergic neurons in the brain. |
2023-11-01 |
2023-11-08 |
human |
| Bingyun Li, Yujia Jiang, Ting Wang, Weiwei Liu, Xiaojuan Chen, Jinyi He, Zeyu Du, Ruijiao Yang, Danxiu Miao, Yanshu L. MicroRNA-217-5p triggers dopaminergic neuronal degeneration via autophagy activation under Atrazine exposure. Environmental pollution (Barking, Essex : 1987). vol 340. issue Pt 1. 2023-10-31. PMID:37890694. |
taken together, these results suggest that atr-induced autophagy can accelerate the progression of neurodegenerative diseases and that mir-217-5p is probably an important target involved in atr-induced dopaminergic damage, shedding important light on the development of a novel strategy for treating neurodegenerative diseases. |
2023-10-31 |
2023-11-08 |
Not clear |
| Seon-Young Park, HyeJin Yang, Soyoung Kim, Juwon Yang, Hyemin Go, Hyunsu Ba. Alpha-Synuclein-Specific Regulatory T Cells Ameliorate Parkinson's Disease Progression in Mice. International journal of molecular sciences. vol 24. issue 20. 2023-10-30. PMID:37894917. |
parkinson's disease (pd) is a long-term neurodegenerative disease characterized by dopaminergic neuronal loss and the aggregation of alpha-synuclein (α-syn) in the brain. |
2023-10-30 |
2023-11-08 |
mouse |
| Su Hyoun Lee, Kwang Chul Chun. USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7. PloS one. vol 18. issue 10. 2023-10-27. PMID:37874827. |
parkinson's disease (pd) is a common neurodegenerative disease (ndd) characterized by the loss of dopaminergic neurons in the substantia nigra. |
2023-10-27 |
2023-11-08 |
Not clear |
| Sazan Ismael, Robert A Colvin, Daewoo Le. Activation of cyclic AMP signaling pathway in dopaminergic neurons rescues locomotion defects in a Drosophila larval model of Parkinson's disease. Brain research. 2023-10-22. PMID:37866407. |
parkinson's disease (pd) is a neurodegenerative disease showing uncontrollable motor symptoms that are primarily caused by the progressive loss of dopaminergic neurons in the brain. |
2023-10-22 |
2023-11-08 |
drosophila_melanogaster |
| Ridhima Vij, Alan Prossin, Mallika Tripathy, Hosu Kim, Hyeonggeun Park, Thanh Cheng, Djamchid Lotfi, Donna Chan. Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report. Frontiers in neurology. vol 14. 2023-10-16. PMID:37840944. |
parkinson's disease (pd) is a neurodegenerative disease that involves the loss of dopaminergic neurons in the substantia nigra pars compacta of the basal ganglia. |
2023-10-16 |
2023-11-08 |
Not clear |
| Yalan Chen, Junxin Kuang, Yimei Niu, Hongyao Zhu, Xiaoxia Chen, Kwok-Fai So, Anding Xu, Lingling Sh. Multiple factors to assist human-derived induced pluripotent stem cells to efficiently differentiate into midbrain dopaminergic neurons. Neural regeneration research. vol 19. issue 4. 2023-10-16. PMID:37843228. |
midbrain dopaminergic neurons play an important role in the etiology of neurodevelopmental and neurodegenerative diseases. |
2023-10-16 |
2023-11-08 |
human |
| Amin A Hafi. The neuroprotective effect of vitamin D in Parkinson's disease: association or causation. Nutritional neuroscience. 2023-09-21. PMID:37731327. |
parkinson's disease (pd) is a chronic neurodegenerative disease (ndd) due to the degeneration of dopaminergic neurons (dns) in the substantia nigra (sn). |
2023-09-21 |
2023-10-07 |
Not clear |